Apurinic/apyrimidinie endonuclease (Ap endo) is a key DNA repair activity t
hat confers resistance to ionizing radiation and alkylating agents in human
cell lines. The major Ap endo in human cells is Ape1, an abundant multi-fu
nctional protein also known as Ref-1, Hap-1, and Apex. In this work, we ass
ayed Ap endo activity in human adult gliomas to establish correlates with t
umor characteristics, and in histologically normal brain adjacent to tumors
to characterize changes in activity accompanying neurocarcinogenesis. To o
ur knowledge, this is the first available analysis of Ap endo activity in h
uman brain tumors. Mean activity in 84 gliomas of different diagnostic type
s and grades was 0.072 +/-0.095 fmol abasic sites incised/cell/min; ranging
similar to 550-fold from 0.00077 to 0.42. The mean for high-grade gliomas
was 3.5-fold greater than for low-grade tumors (P less than or equal to4.0x
10(-5)), a difference observed within all diagnostic types. Activity was co
rrelated with the fraction of S-phase cells in diploid gliomas (P less than
or equal to0.02), suggesting that proliferation could be a determinant of
activity in these tumors. Activity was also correlated with S-phase fractio
n in the majority of aneuploid gliomas (P less than or equal to0.03). Moreo
ver, within the aneuploid tumors, there was a significant relationship betw
een activity and the fraction of aneuploid cells (P less than or equal to4.
0x10(-4)). In, the 58 cases analyzed, mean activity was 7.3-fold higher in
gliomas than mi adjacent histologically normal brain (0.070 +/-0.10 versus
0.0096 +/-0.012 fmol/cell/min; P less than or equal to3.0x10(-5)). Increase
d tumor activity was observed in 93% of tumor/normal pairs, indicating that
elevation of Ap endo activity is characteristic of human gliomagenesis. Th
e elevation was large within most pairs, being 13-fold on average and great
er than or equal to 10-fold in 43% of cases. A concomitant increase in Ape1
protein was observed by Western blotting in the subset of tumor/normal pai
rs, examined. A clinically important consequence of the increase in Ap endo
activity that accompanies neurocarcinogenesis may be enhanced resistance t
o the radiotherapy and alkylating agent-based chemotherapy that are mainsta
ys of adjuvant therapy for malignant gliomas.